- Home
- PLRX vs FFWM Comparison
PLRX vs FFWM Comparison
Compare PLRX & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- FFWM
- Stock Information
- Founded
- PLRX 2015
- FFWM 1990
- Country
- PLRX United States
- FFWM United States
- Employees
- PLRX N/A
- FFWM N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- FFWM Major Banks
- Sector
- PLRX Health Care
- FFWM Finance
- Exchange
- PLRX Nasdaq
- FFWM Nasdaq
- Market Cap
- PLRX 682.2M
- FFWM 510.5M
- IPO Year
- PLRX 2020
- FFWM 2014
- Fundamental
- Price
- PLRX $11.07
- FFWM $6.40
- Analyst Decision
- PLRX Strong Buy
- FFWM Buy
- Analyst Count
- PLRX 7
- FFWM 4
- Target Price
- PLRX $40.50
- FFWM $6.75
- AVG Volume (30 Days)
- PLRX 544.0K
- FFWM 486.5K
- Earning Date
- PLRX 02-26-2025
- FFWM 01-30-2025
- Dividend Yield
- PLRX N/A
- FFWM 0.31%
- EPS Growth
- PLRX N/A
- FFWM N/A
- EPS
- PLRX N/A
- FFWM N/A
- Revenue
- PLRX N/A
- FFWM $108,182,000.00
- Revenue This Year
- PLRX N/A
- FFWM N/A
- Revenue Next Year
- PLRX N/A
- FFWM $31.36
- P/E Ratio
- PLRX N/A
- FFWM N/A
- Revenue Growth
- PLRX N/A
- FFWM N/A
- 52 Week Low
- PLRX $10.22
- FFWM $4.84
- 52 Week High
- PLRX $18.92
- FFWM $11.47
- Technical
- Relative Strength Index (RSI)
- PLRX 36.41
- FFWM 50.03
- Support Level
- PLRX $10.94
- FFWM $6.00
- Resistance Level
- PLRX $12.70
- FFWM $6.38
- Average True Range (ATR)
- PLRX 0.77
- FFWM 0.27
- MACD
- PLRX -0.18
- FFWM 0.09
- Stochastic Oscillator
- PLRX 4.69
- FFWM 94.38
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.